These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34904253)

  • 21. Performance and usefulness of a novel automated immunoassay HISCL SARS-CoV-2 Antigen assay kit for the diagnosis of COVID-19.
    Saito K; Ai T; Kawai A; Matsui J; Fukushima Y; Kikukawa N; Kyoutou T; Chonan M; Kawakami T; Hosaka Y; Misawa S; Takagi H; Matsushita Y; Hiki M; Okuzawa A; Hori S; Naito T; Miida T; Takahashi K; Tabe Y
    Sci Rep; 2021 Dec; 11(1):23196. PubMed ID: 34853366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactivated SARS-CoV-2.
    Yue L; Cao H; Xie T; Long R; Li H; Yang T; Yan M; Xie Z
    J Med Virol; 2021 Mar; 93(3):1732-1738. PubMed ID: 32965677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of magnetic particle-based chemiluminescence immunoassay for measurement of SARS-CoV-2 nucleocapsid protein.
    Xu Y; Xia C; Zeng X; Qiu Y; Liao M; Jiang Q; Quan M; Liu R
    J Virol Methods; 2022 Apr; 302():114486. PubMed ID: 35108595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal Antibodies to S and N SARS-CoV-2 Proteins as Probes to Assess Structural and Antigenic Properties of Coronaviruses.
    Kumar R; Christensen ND; Kaddis Maldonado RJ; Bewley MC; Ostman A; Sudol M; Chen EC; Buchkovich NW; Gontu A; Surendran Nair M; Nissly RH; Minns AM; Kapur V; Rossi R; Kuchipudi SV; Lindner SE; Parent LJ; Flanagan JM; Buchkovich NJ
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients.
    Yang L; Xu Q; Yang B; Li J; Dong R; Da J; Ye Z; Xu Y; Zhou H; Zhang X; Liu L; Zha Y; Yu F
    BMC Microbiol; 2021 Dec; 21(1):351. PubMed ID: 34922455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of Detection Antibody Targeting the Linear Epitope in SARS-CoV-2 Nucleocapsid Protein with Ultra-High Sensitivity.
    Wu F; Jiang Y; Yang H; Ma L
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunodominant regions prediction of nucleocapsid protein for SARS-CoV-2 early diagnosis: a bioinformatics and immunoinformatics study.
    Dai Y; Chen H; Zhuang S; Feng X; Fang Y; Tang H; Dai R; Tang L; Liu J; Ma T; Zhong G
    Pathog Glob Health; 2020 Dec; 114(8):463-470. PubMed ID: 33198594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis.
    Zhang L; Zheng B; Gao X; Zhang L; Pan H; Qiao Y; Suo G; Zhu F
    Front Immunol; 2020; 11():595970. PubMed ID: 33281824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Multiplex Microsphere IgG Assay for SARS-CoV-2 Using ACE2-Mediated Inhibition as a Surrogate for Neutralization.
    Cameron A; Porterfield CA; Byron LD; Wang J; Pearson Z; Bohrhunter JL; Cardillo AB; Ryan-Muntz L; Sorensen RA; Caserta MT; Angeloni S; Hardy DJ; Zand MS; Pecora ND
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical performance of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins.
    Favresse J; Cadrobbi J; Eucher C; Elsen M; Laffineur K; Dogné JM; Douxfils J
    J Med Virol; 2021 Apr; 93(4):2262-2269. PubMed ID: 33200836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
    Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
    Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Integrated Platform for Serological Detection and Vaccination of COVID-19.
    Wei SC; Hsu WT; Chiu CH; Chang FY; Lo HR; Liao CY; Yang HI; Chou YC; Tsai CH; Chao YC
    Front Immunol; 2021; 12():771011. PubMed ID: 35003088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Clinical Evaluation of an Immunochromatography-Based Rapid Antigen Test (GenBody™ COVAG025) for COVID-19 Diagnosis.
    Kim D; Lee J; Bal J; Seo SK; Chong CK; Lee JH; Park H
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33946860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toolkit for Quickly Generating and Characterizing Molecular Probes Specific for SARS-CoV-2 Nucleocapsid as a Primer for Future Coronavirus Pandemic Preparedness.
    Sherwood LJ; Hayhurst A
    ACS Synth Biol; 2021 Feb; 10(2):379-390. PubMed ID: 33534552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic Testing for SARS-CoV-2 Infection from the Antigen Perspective.
    Li D; Li J
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33318065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foundation and Clinical Evaluation of a New Method for Detecting SARS-CoV-2 Antigen by Fluorescent Microsphere Immunochromatography.
    Zhang C; Zhou L; Du K; Zhang Y; Wang J; Chen L; Lyu Y; Li J; Liu H; Huo J; Li F; Wang J; Sang P; Lin S; Xiao Y; Zhang K; He K
    Front Cell Infect Microbiol; 2020; 10():553837. PubMed ID: 33330119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serological Assays for Assessing Postvaccination SARS-CoV-2 Antibody Response.
    Mahmoud SA; Ganesan S; Naik S; Bissar S; Zamel IA; Warren KN; Zaher WA; Khan G
    Microbiol Spectr; 2021 Oct; 9(2):e0073321. PubMed ID: 34585943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
    Li G; Wang A; Chen Y; Sun Y; Du Y; Wang X; Ding P; Jia R; Wang Y; Zhang G
    Front Immunol; 2021; 12():635677. PubMed ID: 33777026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.
    Ogata AF; Maley AM; Wu C; Gilboa T; Norman M; Lazarovits R; Mao CP; Newton G; Chang M; Nguyen K; Kamkaew M; Zhu Q; Gibson TE; Ryan ET; Charles RC; Marasco WA; Walt DR
    Clin Chem; 2020 Dec; 66(12):1562-1572. PubMed ID: 32897389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.